Jennison Associates LLC Biogen Inc. Call Options Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $7.77 Million - $12.4 Million	-30,000 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $2.43 Million - $2.85 Million	10,000 Added 50.0%	30,000 $8.39 Million
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $1.18 Million - $1.78 Million	-5,000 Reduced 20.0%	20,000 $4.9 Million
Q4 2017 Jan 25, 2018	BUY	$307.64 - $344.58 $7.69 Million - $8.61 Million	25,000	25,000 $7.96 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.